Clinical Trial Update: Paxil CR Bioequivalence Study Brazil [Phase 1]

View source ↗

Summary

Phase 1 bioequivalence study of Paxil CR conducted in Brazil has completed and results have been posted. The study assessed treatment for Depressive Disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Depressive Disorder

Drugs mentioned

• Paxil CR (paroxetine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Depressive Disorder | Phase 1 | Status: COMPLETED | Results posted: 2011-04-18